Milestone Pharmaceuticals Inc
Follow $MIST
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $MIST by emailVeridion Score
BETAMEDIUM CONF · 6 of 6 factors measuredHighest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is MIST moving today?
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
MIST overview
Related filings and maps
Congress activity in MIST
No receipt-qualified Congressional disclosure is present for MIST in the cached public ledger.
MIST contract awards, year to date.
Public federal awards linked to this ticker.
MIST lobbying filings, year to date.
Registered lobbying filings matched to Milestone Pharmaceuticals Inc.